QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Appoints Dr. Peter Novak to Scientific Advisory Board
Endonovo Therapeutics Inc. (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical(TM) therapeutic devices, this morning announced its appointment of Peter Novak, M.D., Ph.D., to its scientific advisory board. According to the update, Novak is a board-certified neurologist and autonomic specialist who serves as the director of the Autonomic Laboratory at the Department of Neurology, Brigham and Women’s Hospital in Boston, Massachusetts. In addition, he is a member of the American Academy of Neurology, the American Autonomic Society and the Autonomic Board of United Council for Neurologic Subspecialties. “The Endonovo team is delighted to welcome Dr. Novak to the Scientific Board,”…